Review decision: July 2016
We checked this guideline and decided that it should not be updated at this time. For details, see the update decision, decision matrix, response to stakeholder comments and the process for deciding if an update is needed.
Next review date: 2019
This guideline covers the management of atopic eczema in children from birth up to the age of 12 years, and provides guidance on diagnosis and assessment, management, and providing information and education for children and their parents and carers.
It was previously called atopic eczema in children: management of atopic eczema in children from birth up to the age of 12 years.
Atopic eczema (often called atopic dermatitis) is one of a group of related, inherited conditions that also includes asthma and hay fever. It can make the skin dry, itchy, red, broken and sore. It sometimes makes the skin darker or lighter for a while. People of all ages can get atopic eczema, but it usually starts in early childhood. It usually improves with age, but some people will have the condition into adulthood.
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.